Physician profile
Carson Wayne Homer
NPI 1306462304
$1,296.49
in general payments reported to CMS, 2019-2025
18 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $173 · 2023: $330 · 2024: $361 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $768.15 | 2021-2025 | |
| Lilly USA, LLC | $104.57 | 2023-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $96.89 | 2021-2024 | Shingrix, Arexvy |
| Daiichi Sankyo INC. | $41.10 | 2021 | |
| Novo Nordisk INC | $38.81 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $30.04 | 2021 | |
| Baxter Healthcare | $29.20 | 2022 | |
| Mayne Pharma Commercial LLC | $21.90 | 2023 | |
| Tris Pharma INC | $21.09 | 2023 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $20.94 | 2024 | Spravato |
| Dexcom, INC. | $17.37 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $17.32 | 2022 | |
| Cranial Technologies, INC | $16.70 | 2021 | |
| Neurocrine Biosciences, INC. | $15.63 | 2025 | |
| Merck Sharp & Dohme LLC | $14.97 | 2025 | Gardasil 9, Capvaxive, Enflonsia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $14.81 | 2025 | Airsupra |
| Agile Therapeutics, INC. | $13.91 | 2023 | Twirla |
| Exeltis, USA INC. | $13.09 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Homer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.